Form 4: Assertio Holdings Director Receives Stock and Options as Part of Board Appointment

Mark L. Reisenauer, a new director at Assertio Holdings, received 53,750 restricted stock units and 81,225 stock options as part of his initial board appointment.

Summary

• Mark L. Reisenauer, a director at Assertio Holdings, received 53,750 restricted stock units and 81,225 stock options on January 2, 2025.
• The stock units and options were granted as part of his initial appointment to the Board of Directors.
• The restricted stock units will vest in three equal installments on January 2, 2026, 2027, and 2028, contingent on continued service.
• The stock options also vest in three equal installments on January 2, 2026, 2027, and 2028, contingent on continued service.
• The exercise price for the stock options is $0.85.
• No consideration was paid by Mr. Reisenauer for these derivative securities.

Sentiment

Score: 7

Explanation: The document reflects a standard practice of director compensation, which is generally viewed positively as it aligns interests. There are no negative implications.

Positives

• The grant of stock and options aligns the director's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the director.

Risks

• The vesting of the stock and options is contingent on continued service, which could be a risk if the director leaves the board before full vesting.

Future Outlook

The vesting of the stock and options is contingent on continued service through the applicable vesting dates.

Industry Context

This type of equity grant is a common practice for compensating board members in publicly traded companies, aligning their interests with those of shareholders.

Comparison to Industry Standards

• Equity grants to board members are a standard practice across the pharmaceutical and biotech industries.
• Companies like Teva Pharmaceuticals and Mylan (now Viatris) also use stock options and restricted stock units as part of their director compensation packages.
• The vesting schedules are also typical, with three-year vesting periods being common to encourage long-term commitment.

Management Changes

Stakeholder Impact

• Shareholders may view this positively as it aligns the director's interests with the company's performance.
• The director is incentivized to contribute to the company's success due to the vesting schedule.

Key Dates

Keywords

stock options, restricted stock units, director compensation, board of directors, equity grant, vesting, insider trading, form 4, ASRT, Assertio Holdings